What it sells
AI compliance platform for regulated industries: compliant messaging tools (Shaperon Email, Shaperon Connect), monitoring AI and webinar digest AI.
Business model breakdown
Buyer: who owns the budget?
Pharma compliance / medical affairs
Trigger: what makes them buy now?
Pharma promotional-material review and adverse-event checks done manually; e.g. source-consistency checks took up to 30 minutes.
Workflow: what inputs become what output?
Compliance review of HCP communications
Economics: what it saves and how it charges
Content-production AI offered 'as fast as 5 business days at one third the cost'.
Distribution: how it reaches customers
Separate product sites per AI product, conference talks (Pharma Innovation EXPO, MDMD, PharmaIT), customer press releases, and acquisition of an SDI safety-information service firm.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-01-13 | Series B | JPY 730M | ALL STAR SAAS FUND, Nippon Life Capital, i-nest capital, Vertex Ventures Japan, AGS Consulting | thebridge.jp |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.